Our Annual AMR Symposium will be taking place on Thursday June 5th! Come hear from Man-Wah Tan our keynote speaker and enjoy faculty short talks, trainee flash talks and poster presentations! There will also be a career insight lunch for trainees and a networking reception
please note Cefazolin simply not available in many LMICs, particularly in subsaharan africa and that's what drives use of ASPs there rather than pure dogma
🔥 Big news for TB preventive therapy !
Thanks to 🇨🇦 (😉 🇺🇸), McGill university and Dr Dick Menzies
➡️ New versions TSTin4D (https://t.co/12yZ0XJVys) or IGRAin4D (https://t.co/VjXduxHJkD)
#IDXposts
Antimicrobial resistance (AMR) is when microbes change so that drugs that previously worked don’t anymore. Antibiotic misuse is the leading cause of AMR. Dr. Makeda Semret is testing a new tool to address this.
Learn more: https://t.co/Cr9xUeRoeF
#WAAW#OneHealth@MSemret
join us @mcgillu@cusm_muhc@McGillTropMed@McGillAMRCentre for what promises to be insightful discussions on the role of diagnostics in containing AMR, from a gifted former ID-Micro clinician turned visionary industry exec!
Join us on November 21st for a WAAW week special Seminar + Social with a talk by Dr. Mark Miller. Registration is required, please sign up using the QR code or at https://t.co/aOiyJ2kDNq
🔍👁️ 🍄 “Based on available evidence, and high risk of morbidity of eye involvement, continued ophthalmological screens seem prudent, but a definitive consensus was found to be challenging given a lack of outcome data. Additional investigations are warranted. Ophthalmology screenings have a higher sensitivity at >7 days from positive blood culture.”
https://t.co/Qh79beMSOo in @OFIDJournal #IDxPosts
Dr. Herman Barkema @UCalgary will lead a training platform to help future health research leaders apply #OneHealth approaches to the fight against antimicrobial resistance—a growing health threat in Canada and abroad.
https://t.co/7qAf4DvJke
Patrick Lawler, Dick Menzies, Ruth Sapir-Pichhadze @sapir_ruth, and Makeda Semret @MSemret earn > $11 million from @CIHR_IRSC! Félicitations et merci pour votre dévouement en matière des essais cliniques !
https://t.co/KlyPWumSle
@McGill_TB@cusm_muhc@McGillMed